Domů
Diagnostika, reagencie a spotřební materiál
Infekční sérologie
Diagnostika EUROIMMUN - nepřímá imunofluorescence (IFA), ELISA, imunoblot a westernblot (WB)
Influenza virus
Influenza virus
Dokumenty ke stažení
Influenza virus
|
Objednací |
Specificita protilátky/ reagencie/ analyt |
Ig |
Substrát |
Druh |
Formát
|
|
EI 2691-9601 A |
Influenza virus type A |
IgA |
|
semi-quantitative |
96 x 01 |
| EI 2691-9601 G | Influenza virus type A | IgG |
2/20/200 RU/ml |
96 x 01 | |
| EI 2691-9601 M | Influenza virus type A incl. IgG/RF absorbent |
IgM |
semi-quantitative |
96 x 01 | |
| EI 2692-9601 A | Influenza virus type B | IgA |
semi-quantitative |
96 x 01 | |
| EI 2692-9601 G | Influenza virus type B | IgG |
2/20/200 RU/ml | 96 x 01 | |
|
EI 2692-9601 M |
Influenza virus type B incl. IgG/RF absorbent |
IgM | semi-quantitative | 96 x 01 | |
|
EI 2721-9601-1 A |
Parainfluenza virus types 1 - 4 (Pool) | IgA | semi-quantitative | 96 x 01 | |
| EI 2721-9601-1 G | Parainfluenza virus types 1 - 4 (Pool) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
| EI 2721-9601-1 M |
Parainfluenza virus types 1 - 4 (Pool) incl. IgG/RF absorbent |
IgM | semi-quantitative | 96 x 01 | |
| FI 2691-1005 A FI 2691-1005 G FI 2691-1005 M FK 2691-1005 |
Influenza virus type A | IgA IgG IgM |
infected cells | EU 50 | 10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) 10 x 05 (single slides) |
| FI 2691-1005-1 A FI 2691-1010-1 A FI 2691-1005-1 G FI 2691-1010-1 G FI 2691-1005-1 M FI 2691-1010-1 M |
Influenza virus type A Influenza virus type B |
IgA IgM |
infected cells infected cells (2 BIOCHIPs per field) |
EU 50 EU 50 |
10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) |
| FI 2692-1005 A FI 2692-1005 G FI 2692-1005 M |
Influenza virus type B | IgA IgG IgM |
infected cells | EU 13 |
10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) |
| FI 2721-1005-1 A FI 2721-1005-1 G FI 2721-1005-1 M |
Mosaic Parainfluenza virus types 1 - 4 | IgA IgG IgM |
4 BIOCHIPs per field: infected cells |
EU 18/9 | 10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) |
| FI 2821-1001-1 G FI 2821-1002-1 G FI 2821-2002-1 G Fi 2821-1001-1 M FI 2821-1002-1 M FI 2821-2002-1 M |
Respiratory Tract Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, RSV, Adenovirus type 3, Influenza virus type S (H1N1 and H3N2) field B: Influenza virus type B, Parainfluenza virus type 1, 2, 3 field C: Parainfluenza virus type 4, Bordetella pertussis and parapertussis, Mycoplasma pneumoniae field D: Coxsackie virus type B1 and A7, Echo virus type 7, Chlamydia pneumoniae field E: Haemophilus influenzae*, Klebsiella pneumoniae*, Legionella pneumophila serotype 1 and 12 |
10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) |
|
| FI 2823-1001-1 G* FI 2823-1002-1 G* FI 2823-1001-1 M* FI 2823-1002-1 M* |
Lymphadenitis Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, HIV-1* and 2*, HHV-6, Rubella virus* field B: measles virus, Mumps virus, Adenovirus type 3, Parainfluenza virus type 1 field C: EBV-CA, EBV-EA, Toxoplasma gondii, Treponema pallidum field D: HSV-1 and -2, CMV, Coxsackie virus type B5 field E: Coxsackie virus type A9, Bartonella henselae, Chlamydia trachomatis and pneumoniae |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 20 x 02 (test system) |
|
| FI 2824-1001-1 G FI 2824-1002-1 G FI 2824-1001-1 M* FI 2824-1002-1 M* |
Central Nervous System Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV field B: Adenovirus type 3, EBV-CA, Treponema pallidum, Toxoplasma gondii field C: HSV-1 and -2, Coxsackie virus type B1 and A7 field D: Echo virus type 7, Borr. afzelii, burgdorferi (CH), garinii field E: CMV, Haemophilus influenzae*, Listeria monocytogenes 1/2a and 4b |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 20 x 02 (test system) |
|
| FI 2825-1001-1 G FI 2825-1002-1 G FI 2825-1001-1 M FI 2825-1002-1 M |
Myocarditis Profile 1 (consisting of 17 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) |
||
| FI 2826-1001-1 G FI 2826-1002-1 G FI 2826-1001-1 M FI 2826-1002-1 M |
Infectious Arthritis Profile 1 (consisting of 13 different substrates) |
IgG IgM |
field A: verification BIOCHIP, VZV, Influenza virus type A (H1N1 and H3N2) and B field B: Yersinia enterocolitica O:3*, O:6*, O:9*, Toxoplasma gondii field C: Borrelia afzelii, burgdorferi (CH), garinii, Chlamydia trachomatis |
||
| CI 2691-0101 A | antibodies against Influenza virus type A IgA positive control |
IgA | 0.1 ml |
||
| CI 2691-0101 Z | Influenza virus type A/B negative control |
IgA, IgG, IgM | 0.1 ml | ||
| CI 2691-0101 G | antibodies against Influenza virus type A IgG positive control | IgG | 0.1 ml | ||
| CI 2691-0101 M | antibodies against Influenza virus type A IgM positive control |
IgM | 0.1 ml | ||
| CI 2692-0101 A | antibodies against Influenza virus type B IgA positive control |
IgA | 0.1 ml | ||
| CI 2692-0101 G | antibodies against Influenza virus type B IgG positive control |
IgG | 0.1 ml | ||
| CI 2692-0101 M | antibodies against Influenza virus type B IgM positive control |
IgM | 0.1 ml | ||
| CI 2720-0101 A | antibodies against Parainfluenza virus type 1 - 4 IgA positive control |
IgA | 0.1 ml | ||
| CI 2720-0101 Z | Parainfluenza virus negative control | IgA, IgG, IgM | 0.1 ml | ||
| CI 2720-0101 G | antibodies against Parainfluenza virus type 1 - 4 IgG positive control |
IgG | 0.1 ml | ||
| CI 2720-0101 M | antibodies against Parainfluenza virus type 1 - 4 IgM positive control |
IgM | 0.1 ml |
*) Currently not available as IVD in the European Union.
Technické informace o Influenza virus
Influenza virus
Přejít na odkazZáruka Influenza virus
1 Influenza virus
2 Influenza virus
3 Influenza virus
4 Influenza virus
5 Influenza virus
6 Influenza virus
7 Influenza virus
8 Influenza virus
9 Influenza virus
10 Influenza virus
- Výrobce: EUROIMMUN
Influenza virus
|
Objednací |
Specificita protilátky/ reagencie/ analyt |
Ig |
Substrát |
Druh |
Formát
|
|
EI 2691-9601 A |
Influenza virus type A |
IgA |
|
semi-quantitative |
96 x 01 |
| EI 2691-9601 G | Influenza virus type A | IgG |
2/20/200 RU/ml |
96 x 01 | |
| EI 2691-9601 M | Influenza virus type A incl. IgG/RF absorbent |
IgM |
semi-quantitative |
96 x 01 | |
| EI 2692-9601 A | Influenza virus type B | IgA |
semi-quantitative |
96 x 01 | |
| EI 2692-9601 G | Influenza virus type B | IgG |
2/20/200 RU/ml | 96 x 01 | |
|
EI 2692-9601 M |
Influenza virus type B incl. IgG/RF absorbent |
IgM | semi-quantitative | 96 x 01 | |
|
EI 2721-9601-1 A |
Parainfluenza virus types 1 - 4 (Pool) | IgA | semi-quantitative | 96 x 01 | |
| EI 2721-9601-1 G | Parainfluenza virus types 1 - 4 (Pool) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
| EI 2721-9601-1 M |
Parainfluenza virus types 1 - 4 (Pool) incl. IgG/RF absorbent |
IgM | semi-quantitative | 96 x 01 | |
| FI 2691-1005 A FI 2691-1005 G FI 2691-1005 M FK 2691-1005 |
Influenza virus type A | IgA IgG IgM |
infected cells | EU 50 | 10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) 10 x 05 (single slides) |
| FI 2691-1005-1 A FI 2691-1010-1 A FI 2691-1005-1 G FI 2691-1010-1 G FI 2691-1005-1 M FI 2691-1010-1 M |
Influenza virus type A Influenza virus type B |
IgA IgM |
infected cells infected cells (2 BIOCHIPs per field) |
EU 50 EU 50 |
10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) |
| FI 2692-1005 A FI 2692-1005 G FI 2692-1005 M |
Influenza virus type B | IgA IgG IgM |
infected cells | EU 13 |
10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) |
| FI 2721-1005-1 A FI 2721-1005-1 G FI 2721-1005-1 M |
Mosaic Parainfluenza virus types 1 - 4 | IgA IgG IgM |
4 BIOCHIPs per field: infected cells |
EU 18/9 | 10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) |
| FI 2821-1001-1 G FI 2821-1002-1 G FI 2821-2002-1 G Fi 2821-1001-1 M FI 2821-1002-1 M FI 2821-2002-1 M |
Respiratory Tract Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, RSV, Adenovirus type 3, Influenza virus type S (H1N1 and H3N2) field B: Influenza virus type B, Parainfluenza virus type 1, 2, 3 field C: Parainfluenza virus type 4, Bordetella pertussis and parapertussis, Mycoplasma pneumoniae field D: Coxsackie virus type B1 and A7, Echo virus type 7, Chlamydia pneumoniae field E: Haemophilus influenzae*, Klebsiella pneumoniae*, Legionella pneumophila serotype 1 and 12 |
10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) |
|
| FI 2823-1001-1 G* FI 2823-1002-1 G* FI 2823-1001-1 M* FI 2823-1002-1 M* |
Lymphadenitis Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, HIV-1* and 2*, HHV-6, Rubella virus* field B: measles virus, Mumps virus, Adenovirus type 3, Parainfluenza virus type 1 field C: EBV-CA, EBV-EA, Toxoplasma gondii, Treponema pallidum field D: HSV-1 and -2, CMV, Coxsackie virus type B5 field E: Coxsackie virus type A9, Bartonella henselae, Chlamydia trachomatis and pneumoniae |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 20 x 02 (test system) |
|
| FI 2824-1001-1 G FI 2824-1002-1 G FI 2824-1001-1 M* FI 2824-1002-1 M* |
Central Nervous System Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV field B: Adenovirus type 3, EBV-CA, Treponema pallidum, Toxoplasma gondii field C: HSV-1 and -2, Coxsackie virus type B1 and A7 field D: Echo virus type 7, Borr. afzelii, burgdorferi (CH), garinii field E: CMV, Haemophilus influenzae*, Listeria monocytogenes 1/2a and 4b |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 20 x 02 (test system) |
|
| FI 2825-1001-1 G FI 2825-1002-1 G FI 2825-1001-1 M FI 2825-1002-1 M |
Myocarditis Profile 1 (consisting of 17 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) |
||
| FI 2826-1001-1 G FI 2826-1002-1 G FI 2826-1001-1 M FI 2826-1002-1 M |
Infectious Arthritis Profile 1 (consisting of 13 different substrates) |
IgG IgM |
field A: verification BIOCHIP, VZV, Influenza virus type A (H1N1 and H3N2) and B field B: Yersinia enterocolitica O:3*, O:6*, O:9*, Toxoplasma gondii field C: Borrelia afzelii, burgdorferi (CH), garinii, Chlamydia trachomatis |
||
| CI 2691-0101 A | antibodies against Influenza virus type A IgA positive control |
IgA | 0.1 ml |
||
| CI 2691-0101 Z | Influenza virus type A/B negative control |
IgA, IgG, IgM | 0.1 ml | ||
| CI 2691-0101 G | antibodies against Influenza virus type A IgG positive control | IgG | 0.1 ml | ||
| CI 2691-0101 M | antibodies against Influenza virus type A IgM positive control |
IgM | 0.1 ml | ||
| CI 2692-0101 A | antibodies against Influenza virus type B IgA positive control |
IgA | 0.1 ml | ||
| CI 2692-0101 G | antibodies against Influenza virus type B IgG positive control |
IgG | 0.1 ml | ||
| CI 2692-0101 M | antibodies against Influenza virus type B IgM positive control |
IgM | 0.1 ml | ||
| CI 2720-0101 A | antibodies against Parainfluenza virus type 1 - 4 IgA positive control |
IgA | 0.1 ml | ||
| CI 2720-0101 Z | Parainfluenza virus negative control | IgA, IgG, IgM | 0.1 ml | ||
| CI 2720-0101 G | antibodies against Parainfluenza virus type 1 - 4 IgG positive control |
IgG | 0.1 ml | ||
| CI 2720-0101 M | antibodies against Parainfluenza virus type 1 - 4 IgM positive control |
IgM | 0.1 ml |
*) Currently not available as IVD in the European Union.
- Výrobce: EUROIMMUN
Influenza virus
Přejít na odkazCopyright © DYNEX